|
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1611-1619.
Prepublished online as a Blood First Edition Paper on October 10, 2006; DOI 10.1182/blood-2006-03-008441.
Previous Article | Next Article 
Submitted March 15, 2006
Accepted September 19, 2006
CpG DNA activation and plasma cell differentiation of CD27- naive human B cells
Jennifer Huggins, Tina Pellegrin, Raymond E. Felgar, Chungwen Wei, Miguel Brown, Bo Zheng, Eric C.B. Milner, Steven H. Bernstein, Ignacio Sanz, and Martin S. Zand*
University of Rochester Medical Center
* Corresponding author; email: martin_zand{at}urmc.rochester.edu.
Unmethylated CpG DNA activation of naive CD27- B cells has been reported to require B cell receptor (BCR) cross-linking. We describe a culture system using CpG DNA with sequential steps for T cell independent activation of naive CD19+CD27- human peripheral blood B cells that induces efficient CD138+ plasma cell differentiation. CD27+ and CD27- Cells were cultured in a three step system: (1) Day 0-4: CpG + IL-2/10/15; (2) Day 4-7: IL-2/6/10/15 + anti-CD40L; (3) Day 7-10: IL-6/15, IFN- , hepatocyte growth factor, and hyaluronic acid. Both CD27+ and CD27- B cells up-regulated intracytoplasmic TLR-9 following CpG DNA activation. CD27- B cell activation required cell-cell contact. Both naive and memory B cells progressed to a plasma cell phenotype: CD19lowCD20lowCD27+CD38+HLA-DRlow. 70% of the CD27- derived CD138+ cells demonstrated productive V chain rearrangements without somatic mutations, confirming their origin from naive precursors. Plasma cells derived from CD27+ B cells were primarily IgG+ while those from CD27- B cells were IgM+. Our results indicate that under some conditions naive B-cells increase TLR9 expression and proliferate to CpG DNA stimulation without BCR signaling. In addition to its immunological significance, this system should be a valuable method to interrogate the antigenic specificity of naive B-cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S.-O. Yoon, X. Zhang, P. Berner, and Y. S. Choi
IL-21 and IL-10 have redundant roles but differential capacities at different stages of plasma cell generation from human germinal center B cells
J. Leukoc. Biol.,
December 1, 2009;
86(6):
1311 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Garcia-Bates, C. J. Baglole, M. P. Bernard, T. I. Murant, P. J. Simpson-Haidaris, and R. P. Phipps
Peroxisome Proliferator-Activated Receptor {gamma} Ligands Enhance Human B Cell Antibody Production and Differentiation
J. Immunol.,
December 1, 2009;
183(11):
6903 - 6912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Henn, J. Rebhahn, M. A. Brown, A. J. Murphy, M. N. Coca, O. Hyrien, T. Pellegrin, T. Mosmann, and M. S. Zand
Modulation of Single-Cell IgG Secretion Frequency and Rates in Human Memory B Cells by CpG DNA, CD40L, IL-21, and Cell Division
J. Immunol.,
September 1, 2009;
183(5):
3177 - 3187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora
IFN-{alpha} amplifies human naive B cell TLR-9-mediated activation and Ig production
J. Leukoc. Biol.,
August 1, 2009;
86(2):
261 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Mei, T. Yoshida, W. Sime, F. Hiepe, K. Thiele, R. A. Manz, A. Radbruch, and T. Dorner
Blood-borne human plasma cells in steady state are derived from mucosal immune responses
Blood,
March 12, 2009;
113(11):
2461 - 2469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Douagi, C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sorensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Lore
Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells
J. Immunol.,
February 15, 2009;
182(4):
1991 - 2001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. M. Luo, E. Maarschalk, R. M. O'Connell, P. Wang, L. Yang, and D. Baltimore
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes.
Blood,
February 12, 2009;
113(7):
1422 - 1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Jiang, M. M. Lederman, R. J. Mohner, B. Rodriguez, T. M. Nedrich, C. V. Harding, and S. F. Sieg
Impaired Naive and Memory B-Cell Responsiveness to TLR9 Stimulation in Human Immunodeficiency Virus Infection
J. Virol.,
August 15, 2008;
82(16):
7837 - 7845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Malaspina, S. Moir, A. C. DiPoto, J. Ho, W. Wang, G. Roby, M. A. O'Shea, and A. S. Fauci
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals
J. Immunol.,
July 15, 2008;
181(2):
1199 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Capolunghi, S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al.
CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies
J. Immunol.,
January 15, 2008;
180(2):
800 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-H. Chang, T. McKenzie, G. Bonventi, C. Landolt-Marticorena, P. R. Fortin, D. Gladman, M. Urowitz, and J. E. Wither
Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus
J. Immunol.,
January 15, 2008;
180(2):
1276 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|